Comparing two moisturizers for mild to moderate eczema
Part of Genetic & congenital, Immune system & allergy, Skin clinical trials.
This trial tests if two different moisturizing balms work equally well for treating mild to moderate eczema (atopic dermatitis) in children and adults. It may help find a more affordable or better-tolerated option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 6 months and 70 years old.
- You must have mild to moderate eczema (scored under 40 on the SCORAD scale).
- You must be able to start using the balm within 72 hours of your doctor's checkup.
- You must be part of the French national health insurance and speak French.
- You must sign a consent form.
- You must not have severe eczema that needs stronger medicines.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two prescription creams used to treat mild to moderate eczema (atopic dermatitis) in people aged 2 and older. The goal is to see which cream is safer and works better for reducing symptoms like itching and redness.
This study compares two creams for treating mild to moderate eczema in children: crisaborole 2% and tacrolimus 0.1%. It aims to see which one is more effective and safe for your child.
This study tests a new moisturizing product (RV4421B) for people with mild to moderate atopic dermatitis (eczema). Participants will use the product along with their usual steroid cream for 12 weeks to see how well it works and if it’s safe for different ages, from babies to adults.
This study tests an oral medication (EC-18) for moderate to severe atopic dermatitis (eczema) to see if it can improve symptoms like itching and skin rash. It may be an option for people whose eczema is not controlled by topical treatments.
This trial tests whether a cosmetic cream can reduce eczema flare-ups and is comfortable/safe to use on very dry, irritated, eczema-prone skin. It’s mainly for children who have had recent flare-ups and moderate eczema severity.
This study compares two prescription creams, tacrolimus and crisaborole, to see which works better and is safer for treating mild to moderate eczema over 8 weeks. Both creams are applied to the skin and are alternatives to steroids.
Hear when a new Atopic Dermatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.